Archiwa tagów: sodium salicylate

Dophacyl® Avi – new perspective for poultry health and production performance

Have you ever experienced situations in your work where you felt powerless against symptoms such as lameness in birds and reduced weight gain due to Avian Reoviruses infections, subclinical lesions caused by viral diseases like Infectious Bronchitis or Infectious Bursal Disease or other challenges related to bacterial infections, environmental stressors, metabolic disorders etc.? If so, […]

Dophacyl® Avi: SPC update

Dophacyl® Avi 1000 mg/g is a new and unique veterinary medicine for chickens. Recently, the approval has been expanded, allowing Dophacyl® Avi 1000 mg/g to now also be used with rearing pullets, up to 2 weeks before the start of the laying period. Almost a year ago, Dopharma proudly introduced a new and unique veterinary […]

Sodium salicylate: a versatile link in animal health

Therapeutic support can involve more than just intervention with antibiotics. Additionally, anti-inflammatory therapy can be chosen, where the use of NSAIDs such as sodium salicylate offers significant benefits. Seasonal influences and respiratory diseases The arrival of autumn and winter introduces colder days and nights as well. Changing weather conditions can affect the climate in the […]

Summary Dophacyl Avi webinar

On February 6 2025, we hosted an engaging webinar on a topic that is often overlooked in the poultry industry: pain in chickens. Pain is a universal phenomenon we all recognize, but measuring and identifying it in chickens remains a challenge. While advanced systems already exist for mammals like cows and pigs, research in poultry […]

Dopharma
Przegląd prywatności

Ta strona korzysta z ciasteczek, aby zapewnić Ci najlepszą możliwą obsługę. Informacje o ciasteczkach są przechowywane w przeglądarce i wykonują funkcje takie jak rozpoznawanie Cię po powrocie na naszą stronę internetową i pomaganie naszemu zespołowi w zrozumieniu, które sekcje witryny są dla Ciebie najbardziej interesujące i przydatne.